IDNA ETF
iShares Genomics Immunology and Healthcare ETF
MRNA is IDNA's largest holding at 12.82% of the fund as of Nov 3, 2026. IDNA is iShares Genomics Immunology and Healthcare ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | M | Moderna IncHealth Care · Biotechnology | 12.82% | 12.8% | 221 | $43.04M | Health Care | Biotechnology |
| 2 | — | Genmab ASHealth Care · Biotechnology | 6.51% | 19.3% | 584 | $21.84M | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | T | Twist Bioscience Corp | 6.06% | 25.4% | 152 | $20.32M | ||
| 4 | R | Regeneron Pharmaceuticals Inc | 4.01% | 29.4% | 927 | $13.45M | ||
| 5 | T | Takeda Pharmaceutical Co Ltd | 3.77% | 33.2% | 42 | $12.64M | ||
| 6 | B | Bayer AG | 3.71% | 36.9% | 56 | $12.45M | ||
| 7 | — | Caris Life Sciences Inc | 3.62% | 40.5% | 34 | $12.16M | ||
| 8 | E | Exelixis Inc | 3.61% | 44.1% | 69 | $12.12M | ||
| 9 | R | Revolution Medicines Inc | 3.52% | 47.6% | 191 | $11.81M | ||
| 10 | V | Vertex Pharmaceuticals Inc | 3.43% | 51.1% | 558 | $11.52M | ||
| 11 | M | Merck & Company Inc | 3.40% | 54.5% | 149 | $11.40M | ||
| 12 | — | Roche Holding Ag- Genusschein | 3.27% | 57.7% | 490 | $10.96M | ||
| 13 | I | Incyte Corp | 3.22% | 61.0% | 120 | $10.82M | ||
| 14 | I | Iovance Biotherapeutics Inc | 2.83% | 63.8% | 8 | $9.51M | ||
| 15 | — | BioNTech SE ADR | 2.75% | 66.5% | 88 | $9.22M | ||
| 16 | S | Sanofi SA | 2.71% | 69.2% | 89 | $9.11M | ||
| 17 | I | ImmunityBio Inc | 2.69% | 71.9% | 8 | $9.01M | ||
| 18 | I | Ipsen Sa | 2.65% | 74.6% | 175 | $8.89M | ||
| 19 | — | GSK plc | 2.63% | 77.2% | 24 | $8.83M | ||
| 20 | — | Abcellera Biologics Inc. Common Shares | 2.48% | 79.7% | 12 | $8.32M | ||
| 21 | I | IDEAYA Biosciences Inc | 2.29% | 82.0% | 31 | $7.67M | ||
| 22 | — | Ono Pharmaceutical Co. Ltd. Com Stk | 1.39% | 83.4% | 14 | $4.68M | ||
| 23 | N | Novavax Inc | 1.36% | 84.7% | 10 | $4.55M | ||
| 24 | R | Arcus Biosciences Inc | 1.31% | 86.0% | 18 | $4.40M | ||
| 25 | V | Vir Biotechnology Inc | 1.30% | 87.3% | 11 | $4.36M | ||
| 26 | — | CRISPR Therapeutics AG | 1.27% | 88.6% | 51 | $4.26M | ||
| 27 | N | Nuvation Bio Inc Class A | 1.02% | 89.6% | 4 | $3.41M | ||
| 28 | J | Janux Therapeutics Inc | 0.86% | 90.5% | 17 | $2.90M | ||
| 29 | P | Personalis Inc | 0.84% | 91.3% | 15 | $2.83M | ||
| 30 | R | Rigel Pharmaceuticals Inc | 0.79% | 92.1% | 51 | $2.65M | ||
| 31 | K | Kura Oncology Inc | 0.76% | 92.9% | 10 | $2.55M | ||
| 32 | — | Sunshine Lake Pharma Co Ltd | 0.71% | 93.6% | 5 | $2.38M | ||
| 33 | V | Verastem Inc | 0.69% | 94.3% | 9 | $2.32M | ||
| 34 | P | Pacific Biosciences Of California Inc | 0.64% | 94.9% | 2 | $2.16M | ||
| 35 | X | Xencor Inc | 0.58% | 95.5% | 29 | $1.93M | ||
| 36 | C | Corvus Pharmaceuticals Inc | 0.55% | 96.0% | 10 | $1.83M | ||
| 37 | — | Himile Mechanical Science and Technology (Shandong) Co., Ltd | 0.48% | 96.5% | 2 | $1.60M | ||
| 38 | D | Ginkgo Bioworks Holdings Inc | 0.45% | 97.0% | 11 | $1.51M | ||
| 39 | N | Intellia Therapeutics Inc | 0.45% | 97.4% | 12 | $1.52M | ||
| 40 | A | Alvotech Sa | 0.45% | 97.9% | 4 | $1.52M | ||
| 41 | V | Valneva SE | 0.38% | 98.3% | 2 | $1.27M | ||
| 42 | C | CytomX Therapeutics Inc | 0.35% | 98.6% | 2 | $1.17M | ||
| 43 | D | Design Therapeutics Inc | 0.35% | 99.0% | 10 | $1.16M | ||
| 44 | — | Shanghai Henlius Biotech I Class H | 0.34% | 99.3% | 6 | $1.13M | ||
| 45 | O | Ocugen Inc | 0.20% | 99.5% | - | $676.7K | ||
| 46 | — | Abclon Inc | 0.19% | 99.7% | 13 | $640.7K | ||
| 47 | P | Prime Medicine Inc | 0.12% | 99.8% | 4 | $411.0K | ||
| 48 | Debt | Blackrock Cash Funds: Treasury, Sl Agency Shares | 0.09% | 99.9% | 1 | $292.9K | ||
| 49 | — | Jpy Cash | 0.07% | 100.0% | - | $220.7K | ||
| 50 | — | EUR Cash | 0.02% | 100.0% | 111 | $60.9K | ||
| More holdings · Pro | ||||||||
IDNA ETF All Holdings
IDNA holdings total 62 positions. The top 10 holdings account for 51.1% of the fund, led by Moderna Inc at 12.8%, Genmab AS at 6.5%, Twist Bioscience Corp at 6.1%.
IDNA portfolio concentration is relatively high, with the top 10 representing 51.1% of total assets. The largest sector exposure is Health Care at 77.1%.
IDNA sectors provide a detailed breakdown. IDNA overlap shows how holdings compare to other funds in your portfolio.
IDNA ETF Holdings
62 of 62 holdings
- 1
Moderna Inc
MRNAHealth Care12.82% - 2
Genmab AS
GMAB:COHealth Care6.51% - 3
Twist Bioscience Corp
TWSTHealth Care6.06% - 4
Regeneron Pharmaceuticals Inc
REGNHealth Care4.01% - 5
Takeda Pharmaceutical Co Ltd
4502:JPUnknown3.77% - 6
Bayer AG
BAYN:SGUnknown3.71% - 7
Caris Life Sciences Inc
CAIHealth Care3.62% - 8
Exelixis Inc
EXELHealth Care3.61% - 9
Revolution Medicines Inc
RVMDHealth Care3.52% - 10
Vertex Pharmaceuticals Inc
VRTXHealth Care3.43% - 11
Merck & Company Inc
MRKHealth Care3.40% - 12
Roche Holding Ag- Genusschein
RHO5:FFUnknown3.27% - 13
Incyte Corp
INCYHealth Care3.22% - 14
Iovance Biotherapeutics Inc
IOVAHealth Care2.83% - 15
BioNTech SE ADR
BNTX:FFHealth Care2.75% - 16
Sanofi SA
SAN:PAUnknown2.71% - 17
ImmunityBio Inc
IBRXHealth Care2.69% - 18
Ipsen Sa
IPN:PAUnknown2.65% - 19
GSK plc
GSK:LNUnknown2.63% - 20
Abcellera Biologics Inc. Common Shares
ABCL:CAHealth Care2.48% - 21
IDEAYA Biosciences Inc
IDYAHealth Care2.29% - 22
Ono Pharmaceutical Co. Ltd. Com Stk
4528:JPUnknown1.39% - 23
Novavax Inc
NVAXHealth Care1.36% - 24
Arcus Biosciences Inc
RCUSHealth Care1.31% - 25
Vir Biotechnology Inc
VIRHealth Care1.30% - 26
CRISPR Therapeutics AG
CRSP:SMHealth Care1.27% - 27
Nuvation Bio Inc Class A
NUVBHealth Care1.02% - 28
Janux Therapeutics Inc
JANXHealth Care0.86% - 29
Personalis Inc
PSNLHealth Care0.84% - 30
Rigel Pharmaceuticals Inc
RIGLHealth Care0.79% - 31
Kura Oncology Inc
KURAHealth Care0.76% - 32
Sunshine Lake Pharma Co Ltd
6887:HKUnknown0.71% - 33
Verastem Inc
VSTMHealth Care0.69% - 34
Pacific Biosciences Of California Inc
PACBHealth Care0.64% - 35
Xencor Inc
XNCRHealth Care0.58% - 36
Corvus Pharmaceuticals Inc
CRVSHealth Care0.55% - 37
Himile Mechanical Science and Technology (Shandong) Co., Ltd
2595:SHUnknown0.48% - 38
Ginkgo Bioworks Holdings Inc
DNAHealth Care0.45% - 39
Intellia Therapeutics Inc
NTLAHealth Care0.45% - 40
Alvotech Sa
ALVO:LUUnknown0.45% - 41
Valneva SE
VLA:PAUnknown0.38% - 42
CytomX Therapeutics Inc
CTMXHealth Care0.35% - 43
Design Therapeutics Inc
DSGNHealth Care0.35% - 44
Shanghai Henlius Biotech I Class H
2696:HKUnknown0.34% - 45
Ocugen Inc
OCGNHealth Care0.20% - 46
Abclon Inc
174900:KRUnknown0.19% - 47
Prime Medicine Inc
PRMEHealth Care0.12% - 48
Blackrock Cash Funds: Treasury, Sl Agency Shares
XTSLAFinancials0.09% - 49
Jpy Cash
Other0.07% - 50
EUR Cash
Other0.02% - 51
Cash Collateral USD Hbcft
Other0.01% - 52
USD Cash
Other0.01% - 53
Chf Cash
Other0.01% - 54
Gilead Sciences Inc
GILDUnknown0.00% - 55
OmniAb Inc
OABIHealth Care0.00% - 56
OmniAb Inc
OABIHealth Care0.00% - 57
E-Mini Health Care Sector Dec 26
Other0.00% - 58
HKD Cash
Other0.00% - 59
TWD Cash
Other0.00% - 60
Gbp Cash
Other0.00% - 61
Dkk Cash
Other0.00% - 62
KRW Cash
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 12.820% | ||
| 2 | Genmab AS | GMAB:CO | 6.510% | ||
| 3 | Twist Bioscience Corp | TWST | 6.060% | ||
| 4 | Regeneron Pharmaceuticals Inc | REGN | 4.010% | ||
| 5 | Takeda Pharmaceutical Co Ltd | 4502:JP | 3.770% | ||
| 6 | Bayer AG | BAYN:SG | 3.710% | ||
| 7 | Caris Life Sciences Inc | CAI | 3.620% | ||
| 8 | Exelixis Inc | EXEL | 3.610% | ||
| 9 | Revolution Medicines Inc | RVMD | 3.520% | ||
| 10 | Vertex Pharmaceuticals Inc | VRTX | 3.430% | ||
| 11 | Merck & Company Inc | MRK | 3.400% | ||
| 12 | Roche Holding Ag- Genusschein | RHO5:FF | 3.270% | ||
| 13 | Incyte Corp | INCY | 3.220% | ||
| 14 | Iovance Biotherapeutics Inc | IOVA | 2.830% | ||
| 15 | BioNTech SE ADR | BNTX:FF | 2.750% | ||
| 16 | Sanofi SA | SAN:PA | 2.710% | ||
| 17 | ImmunityBio Inc | IBRX | 2.690% | ||
| 18 | Ipsen Sa | IPN:PA | 2.650% | ||
| 19 | GSK plc | GSK:LN | 2.630% | ||
| 20 | Abcellera Biologics Inc. Common Shares | ABCL:CA | 2.480% | ||
| 21 | IDEAYA Biosciences Inc | IDYA | 2.290% | ||
| 22 | Ono Pharmaceutical Co. Ltd. Com Stk | 4528:JP | 1.390% | ||
| 23 | Novavax Inc | NVAX | 1.360% | ||
| 24 | Arcus Biosciences Inc | RCUS | 1.310% | ||
| 25 | Vir Biotechnology Inc | VIR | 1.300% | ||
| 26 | CRISPR Therapeutics AG | CRSP:SM | 1.270% | ||
| 27 | Nuvation Bio Inc Class A | NUVB | 1.020% | ||
| 28 | Janux Therapeutics Inc | JANX | 0.860% | ||
| 29 | Personalis Inc | PSNL | 0.840% | ||
| 30 | Rigel Pharmaceuticals Inc | RIGL | 0.790% | ||
| 31 | Kura Oncology Inc | KURA | 0.760% | ||
| 32 | Sunshine Lake Pharma Co Ltd | 6887:HK | 0.710% | ||
| 33 | Verastem Inc | VSTM | 0.690% | ||
| 34 | Pacific Biosciences Of California Inc | PACB | 0.640% | ||
| 35 | Xencor Inc | XNCR | 0.580% | ||
| 36 | Corvus Pharmaceuticals Inc | CRVS | 0.550% | ||
| 37 | Himile Mechanical Science and Technology (Shandong) Co., Ltd | 2595:SH | 0.480% | ||
| 38 | Ginkgo Bioworks Holdings Inc | DNA | 0.450% | ||
| 39 | Intellia Therapeutics Inc | NTLA | 0.450% | ||
| 40 | Alvotech Sa | ALVO:LU | 0.450% | ||
| 41 | Valneva SE | VLA:PA | 0.380% | ||
| 42 | CytomX Therapeutics Inc | CTMX | 0.350% | ||
| 43 | Design Therapeutics Inc | DSGN | 0.350% | ||
| 44 | Shanghai Henlius Biotech I Class H | 2696:HK | 0.340% | ||
| 45 | Ocugen Inc | OCGN | 0.200% | ||
| 46 | Abclon Inc | 174900:KR | 0.190% | ||
| 47 | Prime Medicine Inc | PRME | 0.120% | ||
| 48 | Blackrock Cash Funds: Treasury, Sl Agency Shares | XTSLA | 0.090% | ||
| 49 | Jpy Cash | - | 0.070% | ||
| 50 | EUR Cash | - | 0.020% | ||
| 51 | Cash Collateral USD Hbcft | - | 0.010% | ||
| 52 | USD Cash | - | 0.010% | ||
| 53 | Chf Cash | - | 0.010% | ||
| 54 | Gilead Sciences Inc | GILD | 0.000% | ||
| 55 | OmniAb Inc | OABI | 0.000% | ||
| 56 | OmniAb Inc | OABI | 0.000% | ||
| 57 | E-Mini Health Care Sector Dec 26 | - | 0.000% | ||
| 58 | HKD Cash | - | 0.000% | ||
| 59 | TWD Cash | - | 0.000% | ||
| 60 | Gbp Cash | - | 0.000% | ||
| 61 | Dkk Cash | - | 0.000% | ||
| 62 | KRW Cash | - | 0.000% |


































